
AIM ImmunoTech Inc.
AIM ImmunoTech Inc.(AIM)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · AIM · 截至 2026年6月8日
活动摘要
买入笔数
10
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
AIM ImmunoTech Inc.内部人在过去近12个月净买入股份,可能反映对公司前景的信心。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AIM 季度内部人买卖趋势
AIM 内幕交易卖出 · AIM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AIM CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AIM 高管卖出股份 · AIM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 12, 2026 | CHEMEROW DAVID I. Director | Other | 25,000 | — | Form 4 |
| Feb 5, 2026 | CHEMEROW DAVID I. Director | Award | 2,800 | $3K | Form 4 |
| Jun 13, 2025 | Equels Thomas K CEO & President · Director | Purchase | 107 | $824 | Form 4 |
| Jun 12, 2025 | Equels Thomas K CEO & President · Director | Purchase | 103 | $896 | Form 4 |
| Apr 11, 2025 | MITCHELL WILLIAM M Director | Purchase | 196,851 | $5K | Form 4 |
| Apr 11, 2025 | Equels Thomas K CEO & President · Director | Purchase | 1,968,504 | $50K | Form 4 |
| Apr 11, 2025 | KELLNER TED D Director | Purchase | 1,968,504 | $50K | Form 4 |
| Apr 4, 2025 | Equels Thomas K CEO & President · Director | Purchase | 41,000 | $3K | Form 4 |
| Apr 4, 2025 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | 500 | $44 | Form 4 |
| Mar 14, 2025 | MITCHELL WILLIAM M Director | Award | 44,899 | $5K | Form 4 |
| Mar 14, 2025 | BRYAN NANCY Director | Award | 44,899 | $5K | Form 4 |
| Mar 14, 2025 | CHEMEROW DAVID I. Director | Award | 44,899 | $5K | Form 4 |
| Mar 5, 2025 | Equels Thomas K CEO & President · Director | Purchase | 50,000 | $7K | Form 4 |
| Mar 4, 2025 | Equels Thomas K CEO & President · Director | Purchase | 44,000 | $5K | Form 4 |
| Feb 28, 2025 | CHEMEROW DAVID I. Director | Award | 19,290 | $3K | Form 4 |
| Feb 28, 2025 | MITCHELL WILLIAM M Director | Award | 38,580 | $5K | Form 4 |
| Feb 28, 2025 | BRYAN NANCY Director | Award | 38,580 | $5K | Form 4 |
| Mar 4, 2025 | Equels Thomas K CEO & President · Director | Purchase | 83,334 | $10K | Form 4 |
| Feb 14, 2025 | MITCHELL WILLIAM M Director | Award | 43,330 | $5K | Form 4 |
| Feb 14, 2025 | BRYAN NANCY Director | Award | 43,330 | $5K | Form 4 |
| Jan 31, 2025 | MITCHELL WILLIAM M Director | Award | 25,797 | $5K | Form 4 |
| Jan 31, 2025 | BRYAN NANCY Director | Award | 25,797 | $5K | Form 4 |
| Nov 21, 2024 | Equels Thomas K CEO & President · Director | Purchase | 20,000 | $4K | Form 4 |
| Jan 15, 2025 | BRYAN NANCY Director | Award | 27,412 | $5K | Form 4 |
| Jan 15, 2025 | MITCHELL WILLIAM M Director | Award | 27,412 | $5K | Form 4 |
Equels Thomas K
CEO & President · Director
日期
Apr 11
股数
1,968,504
均价
$0.03
总金额
$50K
Rodino Peter W III
COO, Secretary, Gen. Counsel
日期
Apr 4
股数
500
均价
$0.09
总金额
$44
Equels Thomas K
CEO & President · Director
日期
Mar 4
股数
83,334
均价
$0.12
总金额
$10K
Equels Thomas K
CEO & President · Director
日期
Nov 21
股数
20,000
均价
$0.21
总金额
$4K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AIM 内幕交易
AIM 内幕交易
AIM ImmunoTech Inc.(AIM)内幕交易数据来源于公司内部人(包括CHEMEROW DAVID I. (Director), Equels Thomas K (CEO & President · Director))提交的SEC Form 4申报文件。过去12个月内,2位内部人向SEC提交了交易申报。AIM内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看AIM ImmunoTech Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
AIM 内幕交易 · 5个问题AIM ImmunoTech Inc.(AIM)的内部人包括高管和董事,如CHEMEROW DAVID I. (Director), Equels Thomas K (CEO & President · Director)等。过去12个月内,2位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026